near-infrared-photoimmunotherapy-for-mouse-models-pleural

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

The efficacy of photoimmunotherapy can be evaluated more accurately with an orthotopic mouse model than with a subcutaneous one. A pleural dissemination ...

Nagoya University Graduate School of Medicine

Small cell lung cancer (SCLC) has a poor prognosis, and its treatment options are limited. Delta-like protein 3 (DLL3) is expressed specifically in SCLC and is considered a promising therapeutic target for patients with this disease. Rovalpituzumab tesirine (Rova-T) was the first antibody-drug conjugate targeting DLL3. Although Rova-T development was unfortunately terminated, DLL3 remains an ideal target for SCLC. Near infrared photoimmunotherapy (NIR-PIT) is a new form of cancer treatment that employs an antibody-photosensitiser conjugate followed by NIR light exposure and damage target cells specifically. In this study, we demonstrate DLL3-targeted NIR-PIT to develop a novel molecularly targeted treatment for SCLC.

Yoshitaka Isobe

Respiratory Medicine

Nagoya University Graduate School of Medicine

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Yoshitaka Isobe

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Respiratory Medicine

Nagoya University Graduate School of Medicine

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Respiratory Medicine